Similarly, TGF-beta has been associated with a decreased efficacy of anti-PD1 immunotherapy, increasing cancer-associated fibroblasts and as previously mentioned, this leads to a decreased infiltration of the tumour by cytotoxic T-cells [144]. The gene discussed is PDCD1; the disease is cancer.